-
Je něco špatně v tomto záznamu ?
Synergistic interactions of epigallocatechin gallate and oxytetracycline against various drug resistant Staphylococcus aureus strains in vitro
P. Novy, J. Rondevaldova, L. Kourimska, L. Kokoska,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antibakteriální látky farmakologie MeSH
- čaj chemie MeSH
- erythromycin farmakologie MeSH
- katechin analogy a deriváty farmakologie MeSH
- listy rostlin chemie MeSH
- methicilin rezistentní Staphylococcus aureus účinky léků MeSH
- mikrobiální testy citlivosti MeSH
- mnohočetná bakteriální léková rezistence MeSH
- oxytetracyklin farmakologie MeSH
- rezistence na methicilin MeSH
- rezistence na tetracyklin MeSH
- synergismus léků MeSH
- tetracyklin farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Epigallocatechin gallate (EGCG), the major catechin contained in tea leaves, is known to possess the synergistic anti-staphylococcal activity in combination with various β-lactam antibiotics and tetracycline. In the present study, we explored the in vitro combinatory effect of EGCG in combination with oxytetracycline against eight standard strains and clinical isolates of Staphylococcus aureus, including erythromycin, methicillin and tetracycline resistant strains. The minimum inhibitory concentrations were determined by the broth microdilution assay and the data were evaluated according to the sum of fractional inhibitory concentrations (∑FIC). Our results showed synergistic and additive interactions against all S. aureus strains tested (∑FIC 0.288-0.631), two of which were multidrug resistant. According to our best knowledge, it is the first report on the EGCG synergy with oxytetracycline. Considering its significant synergistic antimicrobial effect and low toxicity, we suggest EGCG as a promising compound for the development of new anti-staphylococcal formulations.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031547
- 003
- CZ-PrNML
- 005
- 20131008120006.0
- 007
- ta
- 008
- 131002s2013 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.phymed.2012.12.010 $2 doi
- 035 __
- $a (PubMed)23485046
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Novy, Pavel $u Department of Quality of Agricultural Products, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, Prague 6, Suchdol, Czech Republic.
- 245 10
- $a Synergistic interactions of epigallocatechin gallate and oxytetracycline against various drug resistant Staphylococcus aureus strains in vitro / $c P. Novy, J. Rondevaldova, L. Kourimska, L. Kokoska,
- 520 9_
- $a Epigallocatechin gallate (EGCG), the major catechin contained in tea leaves, is known to possess the synergistic anti-staphylococcal activity in combination with various β-lactam antibiotics and tetracycline. In the present study, we explored the in vitro combinatory effect of EGCG in combination with oxytetracycline against eight standard strains and clinical isolates of Staphylococcus aureus, including erythromycin, methicillin and tetracycline resistant strains. The minimum inhibitory concentrations were determined by the broth microdilution assay and the data were evaluated according to the sum of fractional inhibitory concentrations (∑FIC). Our results showed synergistic and additive interactions against all S. aureus strains tested (∑FIC 0.288-0.631), two of which were multidrug resistant. According to our best knowledge, it is the first report on the EGCG synergy with oxytetracycline. Considering its significant synergistic antimicrobial effect and low toxicity, we suggest EGCG as a promising compound for the development of new anti-staphylococcal formulations.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a katechin $x analogy a deriváty $x farmakologie $7 D002392
- 650 _2
- $a mnohočetná bakteriální léková rezistence $7 D024901
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a erythromycin $x farmakologie $7 D004917
- 650 _2
- $a rezistence na methicilin $7 D016106
- 650 _2
- $a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a oxytetracyklin $x farmakologie $7 D010118
- 650 _2
- $a listy rostlin $x chemie $7 D018515
- 650 _2
- $a čaj $x chemie $7 D013662
- 650 _2
- $a tetracyklin $x farmakologie $7 D013752
- 650 _2
- $a rezistence na tetracyklin $7 D013753
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rondevaldova, Johana $u -
- 700 1_
- $a Kourimska, Lenka $u -
- 700 1_
- $a Kokoska, Ladislav $u -
- 773 0_
- $w MED00003830 $t Phytomedicine : international journal of phytotherapy and phytopharmacology $x 1618-095X $g Roč. 20, č. 5 (2013), s. 432-5
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23485046 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20131008120528 $b ABA008
- 999 __
- $a ok $b bmc $g 995634 $s 829992
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 20 $c 5 $d 432-5 $i 1618-095X $m Phytomedicine $n Phytomedicine $x MED00003830
- LZP __
- $a Pubmed-20131002